A crucial factor of regenerative treatment and drug research lies in the ability to grow human stem cell groups to sufficient quantities for therapeutic applications. Traditionally, restricted cell availability posed a significant barrier to development in these fields. Consequently, considerable effort has been directed towards improving protocols